These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 2194042)
61. Heart transplantation in Norway. Morphological monitoring of cardiac allograft rejection. A 3-year follow-up. Foerster A; Simonsen S; Frøysaker T APMIS; 1988 Jan; 96(1):14-24. PubMed ID: 3278719 [TBL] [Abstract][Full Text] [Related]
62. Imaging in patients after cardiac transplantation and in patients with ventricular assist devices. Gupta B; Jacob D; Thompson R J Nucl Cardiol; 2015 Aug; 22(4):617-38. PubMed ID: 25832983 [TBL] [Abstract][Full Text] [Related]
63. Coronary vasomotor dysfunction in the cardiac allograft: impact of different immunosuppressive regimens. Weis M; Wildhirt SM; Schulze C; Pehlivanli S; Rieder G; Wolf WP; Wilbert-Lampen U; Meiser BM; Enders G; von Scheidt W J Cardiovasc Pharmacol; 2000 Dec; 36(6):776-84. PubMed ID: 11117379 [TBL] [Abstract][Full Text] [Related]
64. Immunoscintigraphy with 111In antimyosin Fab. Morguet AJ; Munz DL; Kreuzer H; Emrich D Nucl Med Commun; 1990 Nov; 11(11):727-35. PubMed ID: 2277688 [TBL] [Abstract][Full Text] [Related]
65. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose. Bonow RO; Dilsizian V; Cuocolo A; Bacharach SL Circulation; 1991 Jan; 83(1):26-37. PubMed ID: 1984883 [TBL] [Abstract][Full Text] [Related]
66. The noninvasive assessment of myocardial viability. Ragosta M; Beller GA Clin Cardiol; 1993 Jul; 16(7):531-8. PubMed ID: 8348761 [TBL] [Abstract][Full Text] [Related]
67. Reduction of tricuspid annular doppler tissue velocities in pediatric heart transplant patients. Fyfe DA; Mahle WT; Kanter KR; Wu G; Vincent RN; Ketchum DL J Heart Lung Transplant; 2003 May; 22(5):553-9. PubMed ID: 12742418 [TBL] [Abstract][Full Text] [Related]
68. Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy? Zakliczynski M; Nozynski J; Konecka-Mrowka D; Krynicka-Mazurek A; Swierad M; Maruszewski M; Przybylski R; Zembala M J Thorac Cardiovasc Surg; 2009 Jul; 138(1):215-21, 221.e1-3. PubMed ID: 19577082 [TBL] [Abstract][Full Text] [Related]
69. Predictors of reduced coronary flow reserve in heart transplant recipients without angiographically significant coronary artery disease. Klauss V; Spes CH; Rieber J; Siebert U; Werner F; Stempfle HU; Uberfuhr P; Theisen K; Angermann CE; Reichart B; Mudra H Transplantation; 1999 Nov; 68(10):1477-81. PubMed ID: 10589942 [TBL] [Abstract][Full Text] [Related]
70. Usefulness of preoperative noninvasive radionuclide testing for detecting coronary artery disease in candidates for liver transplantation. Kryzhanovski VA; Beller GA Am J Cardiol; 1997 Apr; 79(7):986-8. PubMed ID: 9104922 [TBL] [Abstract][Full Text] [Related]
71. No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium. Siebelink HM; Blanksma PK; Crijns HJ; Bax JJ; van Boven AJ; Kingma T; Piers DA; Pruim J; Jager PL; Vaalburg W; van der Wall EE J Am Coll Cardiol; 2001 Jan; 37(1):81-8. PubMed ID: 11153777 [TBL] [Abstract][Full Text] [Related]